Given the significance of the VHL-HIF-1α interaction in determining HIF-1α abundance, efforts have been made to develop small-molecule drugs targeting this interaction for the treatment of conditions like chronic anemia and ischemia [48]. Here, HIF1A is linked to ischemia.